[DOI] [PMC free article] [PubMed] [Google Scholar] 46.Wallace A.S., Chang A.R., Shin J.I., Reider J., Echouffo-Tcheugui J.B., Grams M.E., Selvin E
Waring MJ, Arrowsmith J, Leach AR, Leeson PD, Mandrell S, Owen RM, et al
Notably, Orforglipron (EC 50 1.2 nM), a pyrazolopyridine derivative that acts as a biased partial agonist and is administered orally once daily, has entered Phase III clinical trial (NCT3502970)
Fibromyalgia affects up to 3% of the general population and is a syndrome characterised by widespread pain, fatigue, sleep disturbances, and cognitive dysfunction, somatic symptoms, and psychiatric disorders [90]
Following dehydration in ascending concentrations of ethanol solutions (5 min washes in 50%, 70%, 100%, and 100% ethanol), slides were air-dried, and a hydrophobic barrier was created around the sections using a hydrophobic pen (Vector Labs)